Department of Cancer Prevention, Institute for Cancer Research
Oslo University Hospital, Oslo, Norway
Areas of research
I. Developmental biology of solid tumors. Molecular mechanisms underlying the development of colorectal cancer, testicular cancer and malignant peripheral nerve sheath tumors.
II. Translational research relevant for these three diseases.
Head of Dept. of Cancer Prevention, Norwegian Radium Hospital, Rikshospitalet (RR).
Professor at the Department of Molecular Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo (U of Oslo).
Vice-director of CoE: Centre for Cancer Biomedicine, Faculty of Medicine, U of Oslo.
1981: B.Sc. (Cand. Mag.)- Biology, Chemistry, Mathematics, Faculty of Mathematics and Natural Sciences, University (U) of Bergen
1983: M.Sc. (Cand. Scient.) – Biology, Faculty of Mathematics and Natural Sciences, U of Oslo.
1992: Ph.D. (Dr.philos) – Medicine, Faculty of Medicine, U of Oslo. Suppressor genes involved in tumorigenesis of colon and testis. A molecular and cytogenetic study. ISBN 82-7633-018-5
Scientific advisor (20% position) in molecular diagnostics, Dept. Pathology (1993-2000), and Dept. Cancer Genetics (2001), The Norwegian Radium Hospital (NRH).
Publications in: cancer- genetics and epigenetics, molecular- pathology and oncology
Research group part of
- Centre of excellence: Cancer Biomedicine
- Centre for research based innovation: stem cell based tumor therapy
Awards and honors
2003 The Ragnar Mørk legacy prize
2007 Elected member of the Norwegian Academy of Science and Letters
2007 King Olav the Vth Cancer Research Prize
2007 Medinnova idea prize
Chair of the research council of the Norwegian Cancer Society
Editor-in-Chief: Critical Reviews in Oncogenesis (www.begellhouse.com).
Member of the Research Council for the Rikshospitalet and the U of Oslo (second elected period).
Member of the Comprehensive Cancer Centre Advisory Board for RR.
Member of the Commision of Forensic Medicine, appointed by the Norwegian Ministry of Justice and the Police.
Chair of the board, the Norwegian Centre of Molecular Medicine (NCMM, U of Oslo) with EMBL partnership.
Board member in Oslo Cancer Cluster